Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan

Hepatology Research

Volumn 41, Issue 9, 2011, Pages 877-886

  Tanaka, Atsushi ^a   Harada, Kenichi ^b   Ebinuma, Hirotoshi ^c   Komori, Atsumasa ^d   Yokokawa, Junko ^e   Yoshizawa, Kaname ^f   Abe, Masanori ^g   Miyake, Yasuhiro ^h   Kikuchi, Kentaro ⁱ   Ohira, Hiromasa ^e   Zeniya, Mikio ^j   Yamamoto, Kazuhide ^h   Ishibashi, Hiromi ^d   Onji, Morikazu ^g   Nakanuma, Yasuni ^b   Tsubouchi, Hirohito ^k   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^f SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

ⁱ TEIKYO UNIVERSITY   (Japan)

^j JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KAGOSHIMA UNIVERSITY   (Japan)

more..

Author keywords

Corticosteroids; The revised International Autoimmune Hepatitis Group scoring system; The simplified scoring system

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; BEZAFIBRATE; CORTICOSTEROID; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY; SERUM GLOBULIN; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT INJURY; CLINICAL CHEMISTRY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL PARAMETERS; JAPAN; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PATIENT REFERRAL; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; VALIDATION STUDY;

EID: 80052245126     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00844.x     Document Type: Article

References (30)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. New Engl J Med 2005; 353: 1261-73.
2. Lindor KD, Gershwin ME, Poupon R etal. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
3. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
4. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
5. Beuers U. Hepatic overlap syndromes. J Hepatol 2005; 42 (Suppl): S93-9.
6. Geubel AP, Baggenstoss AH, Summerskill WH. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology 1976; 71: 444-9.
7. Kloppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch A Pathol Anat Histol 1977; 373: 143-60.
8. Beuers U, Rust C. Overlap syndromes. Semin Liver Dis 2005; 25: 311-20.
9. Washington MK. Autoimmune liver disease: overlap and outliers. Mod Pathol 2007; 20 (Suppl 1): S15-30.
10. Alvarez F, Berg P, Bianchi F etal. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-8.
11. Johnson P, McFarlane I. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
12. Silveira MG, Talwalkar JA, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 2007; 102: 1244-50.
13. Talwalkar JA, Keach JC, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 2002; 97: 1191-7.
14. Lohse AW. Recognizing autoimmune hepatitis: Scores help, but no more. J Hepatol 2011; 54: 193-4.
15. Hennes EM, Zeniya M, Czaja AJ etal. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-76.
16. Neuhauser M, Bjornsson E, Treeprasertsuk S etal. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010; 105: 345-53.
17. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28: 296-301.
18. Chazouilleres O, Wendum D, Serfaty L, Rosmorduc O, Poupon R. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006; 44: 400-6.
19. Joshi S, Cauch-Dudek K, Wanless IR etal. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 2002; 35: 409-13.
20. Kuiper EM, Zondervan PE, Buuren HR. Paris Criteria Are Effective in Diagnosis of Primary Biliary Cirrhosis and Autoimmune Hepatitis Overlap Syndrome. Clin Gastroenterol Hepatol 2010; 8: 530-4.
21. Muratori P, Granito A, Pappas G etal. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 2009; 104: 1420-5.
22. Ozaslan E, Efe C, Akbulut S etal. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. Hepatogastroenterology 2010; 57: 441-6.
23. Yokokawa J, Saito H, Kanno Y etal. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. J Gastroenterol Hepatol 2010; 25: 376-82.
24. Heathcote E. Primary Biliary Cirrhosis. In: Schiff E, Sorrell M, Maddrey W, eds. Diseases of the Liver. Philadelphia: Lippincott Williams & Wilkins, 2003; 701-12.
25. Nakanuma Y, Zen Y, Harada K etal. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int 2010; 60: 167-74.
26. Chazouilleres O, Wendum D, Serfety L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28: 296-301.
27. Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2010; 8: 530-4.
28. Talwalkar J, Keach J, Angulo P, Lindor K. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 2002; 97: 1191-7.
29. Boberg KM, Chapman RW, Hirschfield GM etal. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54: 374-85.
30. Ozaslan E. Autoimmune hepatitis-autoimmune cholangitis overlap syndrome and autoimmune thyroiditis in a patient with celiac disease. Eur J Gastroenterol Hepatol 2009; 21: 716-18.